Cortex reposted this
The optimal ablation set beyond PVI for persistent AF patients remains undetermined. Should we go for an anatomical approach (e.g., PWI, VoM, LAAI) or does an personalized approach based on AF mapping still has a role? The randomized FLOW-AF trial demonstrated superiority of EGF-guided ablation vs PVI-only in redo cases (https://lnkd.in/eZNpduKG). The multicenter RESOLVE-AF study will evaluate whether active AF sources identified by OptiMap are clinically relevant in persistent AF patients undergoing their first PVI. This week we enrolled the first patient in the Erasmus MC for RESOLVE-AF. Excited to be part of this endeavor to establish the role of EGF mapping. Thanks to Marloes Jansen for the support. Sip Wijchers, Rohit Bhagwandien, Bakhtawar Khan Mahmoodi, Nick van Boven, Duke Rohlen, Melissa H. Kong, MD, Dr. Philip Haeusser, Erik Harks, Lucas Boersma #CORTEX, #EGF, #OptiMap
These studies continue to advance experience and knowledge focused on helping patients like me! It is clear that you practice your profession with passion and dedication, and this shines through in the excellent care you provide. I will always be grateful to you!
CEO
2wWe are thrilled to have you and your entire team on board and enrolling in our study!